James Rozsa Partner

James is a corporate lawyer specialising in mergers and acquisitions, private equity transactions and equity capital markets.

He advises clients from a variety of industries including private equity sponsors. He is an expert in all aspects of domestic and cross-border M&A deals including public (takeovers and schemes of arrangements) and privately negotiated transactions and ECM deals including cross-border listings on the ASX.

James is qualified in both Australia and the US, and has for many years advised US clients doing business in Australia and Australian clients doing business in the US.

James has been consistently recognised by his peers (Best Lawyers) for each of M&A (since 2010), Private Equity (since 2010), Corporate & Venture Capital Law (since 2010) and by his clients (Chambers) as a leading individual, again for each of Corporate/M&A, Private Equity (2011-2021) and Capital Markets (2016-2021). In Chambers he is described as “easily the best private equity lawyer we have dealt with, especially on cross-border deals”and is regarded as a "solutions-based lawyer who is very hands-on during a deal" and is lauded for producing "high-quality work quickly and with strong client interaction.”

Experience

Private equity and M&A experience

Qantas Airways Limited (ASX:QAN)

Acting for Qantas Airways Limited (ASX:QAN) in its proposed merger with Alliance Services Limited (ASX:AQZ) by way of a scheme of arrangement (2022).

Quantum Health Group Limited (ASX:QTM)

Acting for Quantum Health Group Limited (ASX:QTM) in its merger with Paragon Care Limited (ASX:PGC) by way of a scheme of arrangement (2022).

Vector Capital

Acting for Vector Capital Management and its portfolio company MoxiWorks on its acquisition of ActivePipe, a real estate tech offering providing email and marketing automation solutions (2022).

Lacima Group

Acting for Lacima, which provides technology solutions for trading and risk management in energy and commodities markets trading businesses, to the European Energy Exchange (EEX), which is part of the Deutsche Borse (2022).

Level Equity

Acting for Level Equity in its acquisition of SaaS anti-fraud payment protection technology company eftSure (2021).

GumGum, Inc

Acting for GumGum in relation to its acquisition of attention intelligence platform Playground XYZ (2021).

Spotify AB

Acting for Spotify in its acquisition of podcast tech platform Whooshkaa (2021).

Acclivis Group

Acting in relation to its acquisition of Z Software (2021).

Liverpool Partners

Acting in relation to its acquisition of Baby Village (2021).

Salsify Inc

Acting in relation to its acquisition of SKUvantage (2021).

Beamtree Holdings Limited (ASX:BMT)

Acting in relation to its acquisition of Potential(x) (2021).

Potentia Capital

Acting in relation to its acquisition of SuperChoice Services (2021).

IXUP Limited (ASX:IXU)

Acting in relation to its acquisition of Data Republic (2021).

Thrasio Inc

Acting in relation to a series of acquisitions in Australia (2021).

PLBY Group

Acting for Playboy in relation to its acquisition of Honey Birdette (2021).

Potentia Capital

Acting in relation to its acquisition of NewBook (2021).

Potentia Capital

Acting in relation to its portfolio acquisitions by Micromine of Precision Mining (2021) and Alastri Holdings (2021).

The CapStreet Group

Acting in relation to its portfolio acquisition by Incentive Solutions of OneAffiniti (2021).

Liverpool Partners

Acting in relation to its portfolio acquisitions by Seisma of Smart Apps (2021), coIB (2021) and Braestone (2021).

Bay Grove

Acting in relation to its portfolio acquisition by Lineage Logistics of Emergent Cold (2020).

Potentia Capital

Acting in relation to its acquisition of Commerce Vision (2021).

Virgin Group

Acting in relation to its investment in the Bain Capital consortium for Virgin Australia (2020).

Archer Capital

Acting in relation to its partial divestment of illion (2020).

Liverpool Partners

Acting in relation to its acquisition of Melbourne IT Consulting (2020).

Potentia Capital

Acting in relation to its portfolio acquisition of Premier Technologies, a payments solution (2020).

Insight Partners

Acting in relation to its acquisition of Kumo Holdings (2020).

Archer Capital

Acting in relation to its proposed acquisition of FunLab (2020).

Potentia Capital

Advised on all corporate aspects of Potentia’s acquisition of 100% of PC-EFTPOS (2019).

Marlin Equity

Acting in relation to its acquisition of HotSchedules (formerly RedBook) (2019).

Archer Capital

Acting in relation to its divestment of LCR Group to Qube (2019).

Coast2Coast

Acting in relation to its divestment of Marlin Brands (2019).

Potentia Capital

Advising on its acquisition of Micromine (2018).

Matrix Partners

Advising on its PIPE into Afterpay (ASX:APT) (2018).

JMI Equity

Advising on its acquisition of Serraview Holdings (2018).

PCI Pharma

Advising on its acquisition of Pharmaceutical Packaging (2018).

Archer Capital

Acting in relation to its divestment of AeroCare to Swissport (2018).

Venture capital and growth equity experience

General Catalyst Partners

Acting for General Catalyst Partners in its Series A investment into Carma (2022).

Protecht

Acting for Protecht, a risk management software company, in relation to its Series A financing from Arrowroot Capital (2022).

Potentia Capital

Acting in relation to its investment in EstimateOne, a construction tech company (2021).

JMI Equity

Acting in relation to its investment in Practice Ignition (2021).

Five V Capital

Acting in relation to its investment in Automic Group (2021).

Gemini Investments and Tiger Global Investment

Acting in relation to their investment in Stakeshop (2021).

Insight Partners

Acting in relation to its investment in SafetyCulture (2021).

Insight Partners

Acting in relation to its investment in Octopus Deploy (2021).

Insight Partners

Acting in relation to its investment in Employment Hero (2021).

OpenView Partners

Acting in relation to its investment in Persuit (2021).

Seven West Media Limited

Acting on its portfolio divestment of Airtasker (2021).

Insight Partners

Acting in relation to its investment in Linktree (2020).

OpenView Partners

Acting in relation to its investment in Buildkite (2020).

Seven West Media Limited

Acting on its portfolio investments in Health Engine (2020).

Linktree

Advised on series B funding round of financing (2021).

Bioscience Managers

Acting in relation to its investment in Canary (2020).

Felicis Ventures

Advising on its seed investment in Dovetail (2020).

Clean Energy Finance Corporation

Acting in relation to its investment in Sunman energy (2020).

Ten Eleven Ventures

Advising on its Series B investment in Kasada (2020).

Insight Partners

Advised on its Series B investment of Linktree (2020).

Accel-KKR

Advising on its Series A investment in Pegasus Management (2020).

Bioscience Managers

Acting in relation to its investment in Pharmamark (2019).

Replica Media

Advising on its US-redomicile and seed financing (2019).

Cardiac Dimensions

Acting in relation to on its Series B financing (2018).

Blade Therapeutics, Inc.

Advising on the Initial Closing of its US$50 million Series C round of financing (2018).

Madorra

Advising on on its Series A fundraising (2018).

Accel-KKR

Advising on its series A investment in Humanforce, a workplace management solution (2018).

Institutional Venture Partners and OpenView

Advising on their series C investment in Deputy Group (2018).

Inference Technologies

Advising on its investment by Peakspan Capital (2018).

Khosla Ventures

Advising on its seed investment in Popgun Labs (2018).

Brandon Capital Partners and MH Carnegie & Co

Advising on their investment in EBR Systems (2017).

IPO experience

EBR Systems, Inc (ASX:EBR)

Acting for EBR on its IPO and ASX-listing (2021).

Laybuy Limited (ASX:LBY)

Acting for Laybuy Limited on its pre-IPO and IPO and ASX-listing (2020).

Imricor Medical Systems, Inc (ASX:IMR)

Acting for Imricor Medical Systems on its IPO and ASX-listing (2019).

Visioneering Technologies, Inc (ASX:VTI)

Acting on its IPO and ASX-listing (2017).

AccuVein, Inc

Acting on its proposed IPO and ASX-listing (2017).

AirXpanders, Inc (ASX:AXP)

Acting for AirXpanders on its IPO and ASX-listing (2015).

Other ECM experience

AirXpanders, Inc (ASX:ASX)

Acting for AXP on its follow-on placement (2016, 2017, 2018).

Bioscience Managers

In its PIPE investments in Acrux (ASX:ACR) (2020) and Cynata Therapeutics (ASX:CYP) (2020).

BSA Limited (ASX:BSA)

Acting for BSA on its placement (2014).

Energy Word Corporation (ASX:EWC)

Acting for EWC on various follow-on offerings including note issues and placements (2015).

Hexima Limited (ASX:HXL)

Acting for HXL on its follow-on placement (2021).

Impedimed Limited (ASX:IPD)

Acting for IPD on various follow-on offerings, including rights issues and placements (2014, 2016, 2018, 2020, 2021).

Imricor Medical Systems, Inc (ASX:IMR)

Acting for IMR on various follow-on offerings, including rights issues and placements (2020, 2021).

Matrix Partners

In its PIPE investment in Afterpay (ASX:APT) (2017).

Osprey Medical, Inc (ASX:OSP)

Acting for OSP on numerous follow-on offerings, including rights issues and placements (2015, 2016, 2017, 2018, 2020, 2021).

Peplin Inc (ASX:PLI)

On and numerous fundraisings in Australia and the US.

Sociedad Quimica y Minera (SQM)

Acting for SQM on its PIPE investment into Elemental Minerals Limited (ASX:ELM) (2016).

Sunshine Heart, Inc (ASX: SHI)

On its listing and fundraisings and numerous fundraisings in Australia and the US.

Visioneering Technologies, Inc (ASX:VTI)

Acting for VTI on numerous follow-on offerings, including convertible notes, rights issues and placements (2018, 2019, 2020, 2021).

Recognition

Career & qualifications

Qualifications

  • Bachelor of Laws, Sydney University
  • Bachelor of Arts, Sydney University
  • New York State Bar

International experience

  • Qualified in both Australia and the US, James has closed many deals around the world, including in Sydney, New York, London, Milan, Stockholm and Beijing
  • Experience in North America and Europe as an investment banker
  • For many years advised US clients doing business in Australia and Australian clients doing business in the US, including a number of US med-tech companies on their proposed Australian IPOs and ASX-listings

 

Insights Read more insight

Australia’s media reform and its impact on M&A activity

On 16 October 2017, the Broadcasting Legislation Amendment (Broadcasting Reform) Bill 2017 (Cth) was passed by Australia’s House of Representatives and granted Royal assent. Following the Royal...

More
New FIRB Business Exemption Certificates

There are a number of associated issues and uncertainties regarding a new exemption certificate for business acquisitions by foreign investors (Business EC).

More
Transparency on the beneficial ownership of companies

In February 2017, the Australian Government released a consultation paper titled ‘Increasing Transparency of the Beneficial Ownership of Companies’ (Consultation Paper) to explore the potential to...

More